CLINICAL TRIALS PROFILE FOR NORKETOTIFEN

Clinical Trials for Norketotifen

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT03712163 ↗	Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects	Completed	Emergo Therapeutics, Inc.	Phase 1	This is a Phase 1, single-center, double-blind, randomized, placebo-controlled, 2-part, single ascending dose and multiple dose cohort study of orally administered Norketotifen (NKT) in healthy subjects.
NCT03887026 ↗	Efficacy and Safety of Norketotifen in Adults With Allergic Rhinitis	Completed	Emergo Therapeutics, Inc.	Phase 2	This is a Phase 2a study to evaluate the efficacy and safety of Norketotifen (NKT) in subjects with allergic rhinitis.
NCT04043923 ↗	Norketotifen for the Treatment of Uncomplicated Influenza-like Illness	Completed	Emergo Therapeutics, Inc.	Phase 2	This is a Phase 2b, multi-center, double-blind, randomized, placebo-controlled, parallel-group study of NKT versus placebo in otherwise healthy adults presenting with acute uncomplicated ILI due to influenza or other respiratory viruses in a community setting.

Clinical Trial Conditions for Norketotifen

Condition Name

Condition Name
Intervention	Trials
Influenza -Like Illness	2
Allergic Rhinoconjunctivitis	1
Healthy Subjects	1

Condition MeSH

Condition MeSH
Intervention	Trials
Influenza, Human	2
Rhinitis, Allergic	1
Rhinitis	1

Clinical Trial Locations for Norketotifen

Trials by Country

Trials by Country
Location	Trials
United States	32
Australia	4
New Zealand	1

Trials by US State

Trials by US State
Location	Trials
Texas	4
South Dakota	2
North Carolina	2
Louisiana	2
Florida	2

Clinical Trial Progress for Norketotifen

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase	Trials
Phase 2	3
Phase 1	1

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase	Trials
Completed	3
Recruiting	1

Clinical Trial Sponsors for Norketotifen

Sponsor Name

Sponsor Name
Sponsor	Trials
Emergo Therapeutics, Inc.	4

Sponsor Type

Sponsor Type
Sponsor	Trials
Industry	4